Song X - Search Results

1

Cost-effectiveness of nivolumab combined with chemotherapy as a first-line therapy for patients with unresectable or metastatic urothelial carcinoma.

Lin J, Song X, Fu W, You C, Li N, Liu M, Cai H. Lin J, et al. Among authors: song x. Ther Adv Med Oncol. 2024 Dec 16;16:17588359241301339. doi: 10.1177/17588359241301339. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 39691586 Free PMC article.

2

First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma: a cost-effectiveness analysis.

Cao X, Zhang M, Li N, Zheng B, Liu M, Song X, Cai H. Cao X, et al. Among authors: song x. Ther Adv Med Oncol. 2023 May 16;15:17588359231171038. doi: 10.1177/17588359231171038. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 37223263 Free PMC article.

3

Cost-effectiveness of pembrolizumab for second-line treatment of esophageal squamous cell carcinoma patients with a combined positive score of 10 or more.

Song X, Zheng Z, Li X, Cai H, Zhang L. Song X, et al. J Comp Eff Res. 2022 Apr;11(6):391-397. doi: 10.2217/cer-2021-0112. Epub 2022 Feb 18. J Comp Eff Res. 2022. PMID: 35179053 Free article.

4

Cost-effectiveness analysis of pembrolizumab plus chemotherapy for patients with recurrent or metastatic cervical cancer in China.

Zheng Z, Song X, Qiu G, Xu S, Cai H. Zheng Z, et al. Among authors: song x. Curr Med Res Opin. 2023 Mar;39(3):433-440. doi: 10.1080/03007995.2023.2178081. Epub 2023 Feb 17. Curr Med Res Opin. 2023. PMID: 36757780

5

Pembrolizumab combined with chemotherapy versus placebo combined with chemotherapy for HER2-negative advanced gastric cancer in China: a cost-effectiveness analysis.

Zheng Z, Song X, Cai H, Zhu H. Zheng Z, et al. Among authors: song x. Expert Rev Pharmacoecon Outcomes Res. 2024 Oct;24(8):1017-1025. doi: 10.1080/14737167.2024.2378986. Epub 2024 Jul 12. Expert Rev Pharmacoecon Outcomes Res. 2024. PMID: 38979829

6

First-line nivolumab plus ipilimumab for unresectable MPM in China: a cost-effectiveness analysis.

Yang L, Song X, Zeng W, Zheng Z, Lin W. Yang L, et al. Among authors: song x. Orphanet J Rare Dis. 2023 Oct 16;18(1):326. doi: 10.1186/s13023-023-02925-w. Orphanet J Rare Dis. 2023. PMID: 37845696 Free PMC article.

7

Cost-effectiveness of first-line sintilimab plus chemotherapy versus chemotherapy for advanced esophageal carcinoma in China.

Lin N, Chen S, Zheng Z, Song X. Lin N, et al. Among authors: song x. Expert Rev Pharmacoecon Outcomes Res. 2024 Sep 30:1-9. doi: 10.1080/14737167.2024.2410248. Online ahead of print. Expert Rev Pharmacoecon Outcomes Res. 2024. PMID: 39327693

8

Efficacy of oral treprostinil for treating pulmonary arterial hypertension: a systematic review and meta-analysis.

Xiao L, Feng X, Zhang H, Zhong L, Song X, Wang F. Xiao L, et al. Among authors: song x. Postepy Kardiol Interwencyjnej. 2024 Sep;20(3):258-263. doi: 10.5114/aic.2024.143558. Epub 2024 Sep 27. Postepy Kardiol Interwencyjnej. 2024. PMID: 39464579 Free PMC article. Review.

9

From signal-off to signal-on: polyT linker alters signal response mode and enhances signal change of aptamer beacon probe.

Zhang W, Wang C, Ren K, Song X, Wang Q, Shi P. Zhang W, et al. Among authors: song x. Anal Bioanal Chem. 2025 Jan 3. doi: 10.1007/s00216-024-05704-z. Online ahead of print. Anal Bioanal Chem. 2025. PMID: 39753899

10

D3-ImgNet: A Framework for Molecular Properties Prediction Based on Data-Driven Electron Density Images.

Zhao J, Tang L, Liu J, Wu J, Song X. Zhao J, et al. Among authors: song x. J Phys Chem A. 2025 Jan 3. doi: 10.1021/acs.jpca.4c05519. Online ahead of print. J Phys Chem A. 2025. PMID: 39752232

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19,730 results

Search Page

Filters